Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
The 140 years' journey of gastric cancer surgery: From the two hands of Billroth to the multiple hands of the robot
by
Terashima, Masanori
in
Cancer surgery
/ Clinical trials
/ Disease
/ Dissection
/ extended surgery
/ Gastric cancer
/ Gastrointestinal surgery
/ laparoscopic gastrectomy
/ Laparoscopy
/ Lymphatic system
/ Metastasis
/ Minimally invasive surgery
/ Mortality
/ postoperative complications
/ Review
/ robotic gastrectomy
2021
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
The 140 years' journey of gastric cancer surgery: From the two hands of Billroth to the multiple hands of the robot
by
Terashima, Masanori
in
Cancer surgery
/ Clinical trials
/ Disease
/ Dissection
/ extended surgery
/ Gastric cancer
/ Gastrointestinal surgery
/ laparoscopic gastrectomy
/ Laparoscopy
/ Lymphatic system
/ Metastasis
/ Minimally invasive surgery
/ Mortality
/ postoperative complications
/ Review
/ robotic gastrectomy
2021
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
The 140 years' journey of gastric cancer surgery: From the two hands of Billroth to the multiple hands of the robot
by
Terashima, Masanori
in
Cancer surgery
/ Clinical trials
/ Disease
/ Dissection
/ extended surgery
/ Gastric cancer
/ Gastrointestinal surgery
/ laparoscopic gastrectomy
/ Laparoscopy
/ Lymphatic system
/ Metastasis
/ Minimally invasive surgery
/ Mortality
/ postoperative complications
/ Review
/ robotic gastrectomy
2021
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
The 140 years' journey of gastric cancer surgery: From the two hands of Billroth to the multiple hands of the robot
Journal Article
The 140 years' journey of gastric cancer surgery: From the two hands of Billroth to the multiple hands of the robot
2021
Request Book From Autostore
and Choose the Collection Method
Overview
After the initial achievement by Billroth in 1881, surgery for gastric cancer has become increasingly extended. However, it turned out to be limited in Western countries after the publication that denied the role of extended surgery in the 1960s. While surgeons in Japan were still enthusiastic about extended surgery, the Japan Clinical Oncology Group (JCOG) conducted clinical trials to validate the role of extended surgery. Contrary to expectations, the efficacy of extended surgery was not demonstrated. In gastric cancer surgery, postoperative complications were reported to be associated with poor survival. A survival benefit could not be obtained by extended surgery, with high morbidity. Therefore, the paradigm had been changed from extended surgery to minimally invasive surgery (MIS). As an MIS for gastric cancer, laparoscopic surgery has been considered a practical method. Initial laparoscopic gastrectomy (LG) was first performed by Kitano in 1991. Thereafter, LG became increasingly common. Several clinical trials demonstrated the noninferiority of LG to open gastrectomy. LG is now regarded as the standard for cStage I gastric cancer, and the indication is expanding to advanced cancer. However, LG has some drawbacks owing to the restriction of movement caused by straight‐shaped forceps. Robotic gastrectomy (RG) is considered a major breakthrough to circumvent the drawbacks in LG using articulated devices. However, the solid evidence demonstrating the advantage of RG has not been proved yet. The JCOG is now conducting a randomized controlled trial to evaluate the superiority of RG to LG in terms of reducing morbidity.
Publisher
John Wiley & Sons, Inc,John Wiley and Sons Inc,Wiley
Subject
This website uses cookies to ensure you get the best experience on our website.